Postnatal hematopoiesis and gut microbiota in NOD mice deviate from C57BL/6 mice by Damlund, Dina Silke Malling et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Postnatal hematopoiesis and gut microbiota in NOD mice deviate from C57BL/6 mice
Damlund, Dina Silke Malling; Metzdorff, Stine Broeng; Hasselby, Jane Preuss; Wiese, Maria;
Lundsager, Mia Thorup; Nielsen, Dennis Sandris; Buschard, Karsten Stig; Hansen, Axel
Kornerup; Frøkiær, Hanne
Published in:
Journal of Diabetes Research
DOI:
10.1155/2016/6321980
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Damlund, D. S. M., Metzdorff, S. B., Hasselby, J. P., Wiese, M., Lundsager, M. T., Nielsen, D. S., ... Frøkiær, H.
(2016). Postnatal hematopoiesis and gut microbiota in NOD mice deviate from C57BL/6 mice. Journal of
Diabetes Research, 2016, [6321980]. https://doi.org/10.1155/2016/6321980
Download date: 03. Feb. 2020
Research Article
Postnatal Hematopoiesis and Gut Microbiota in
NOD Mice Deviate from C57BL/6 Mice
Dina Silke Malling Damlund,1 Stine Broeng Metzdorff,1 Jane Preuss Hasselby,2
Maria Wiese,3 Mia Lundsager,1 Dennis Sandris Nielsen,3 Karsten Stig Buschard,4
Axel Kornerup Hansen,1 and Hanne Frøkiær1
1Department of Veterinary Disease Biology, Faculty of Health and Medical Sciences, University of Copenhagen,
1870 Frederiksberg C, Denmark
2Department of Pathology, Rigshospitalet, 2100 Copenhagen, Denmark
3Department of Food Science, University of Copenhagen, 1870 Frederiksberg C, Denmark
4Bartholin Institute, Rigshospitalet, 2100 Copenhagen, Denmark
Correspondence should be addressed to Dina Silke Malling Damlund; msilke@sund.ku.dk
Received 20 May 2015; Revised 9 July 2015; Accepted 21 July 2015
Academic Editor: Urs Christen
Copyright © 2016 Dina Silke Malling Damlund et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Neonatal studies in different mouse strains reveal that early life colonization affects the development of adaptive immunity in mice.
The nonobese diabetic (NOD)mouse spontaneously develops autoimmune diabetes, but neonatal studies of NODmice are lacking.
We hypothesized that NOD mice deviate from another much used mouse strain, C57BL/6, with respect to postnatal microbiota
and/or hematopoiesis and compared this in newborn mice of dams housed under the same conditions. A distinct bacteria profile
rich in staphylococci was found at postnatal days (PND) 1–4 in NOD mice. Furthermore, a distinct splenic cell profile high in a
granulocytic phenotypewas evident in the neonatal NODmicewhereas neonatal C57BL/6mice showed a profile rich inmonocytes.
Neonatal expression of Reg3g andMuc2 in the gut was deviating in NOD mice and coincided with fewer bacteria attaching to the
Mucosal surface in NOD compared to C57BL/6 mice.
1. Introduction
The nonobese diabetic (NOD) mouse spontaneously devel-
ops autoimmune diabetes and provides a suitable rodent
model for research in type 1 diabetes pathogenesis [1, 2].
Host genetics, gut microbiota, and diet-associated factors are
central in the development of diabetes in NOD mice [3–
7]. However, the mechanisms behind the microbiota-host
interaction and the specific genetic deviations leading to the
disease pathology of type 1 diabetes are poorly understood.
The development of autoimmune diabetes in NOD mice
is a result of polygenic interactions. The etiology is complex
[5, 8], with genetics playing an important role, but also other
factors influence the disease pathology [9]. The incidence of
diabetes in NOD mice has been correlated with hygiene and
microbiota in the colony and housing facility [4, 10] and gut
microbiota (GM)dysbiosis have been linked to type 1 diabetes
development [11, 12]. Factors determining GM composition
are complex. Type of delivery and environmental factors have
been implicated to play important roles in the establishment
of GM. Children delivered by caesarean section may display
an increased risk to develop autoimmune diabetes [13] indi-
cating that early life colonization influences the development
of type 1 diabetes.
Postnatal development of the immune system is heavily
influenced by GM [14]. Germ-free mice have an underde-
veloped mucosal epithelium with smaller Peyer’s patches,
fewer isolated lymphoid follicles, and reduced production of
antimicrobial peptides [15]. GM composition is influenced by
antimicrobial peptides [16] and one function of the mucus
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layer is to retain defensins and antimicrobial proteins, such as
the antimicrobial C-type lectin Reg3g, in close proximity to
the epithelial surface [17]. Reg3g is normally expressed from
weaning and restricts the number of surface-associated bac-
teria [16], mainly targetingmucosa-associated Gram-positive
bacteria [18]. In inflammatory bowel disease expression of
the secretedmucus proteinMuc2 is downregulated [19] while
Reg3g expression is increased [20] indicating that Reg3g
expression increases when the mucus layer is disassembled.
It has been suggested that genetic defects involved in the
development of type 1 diabetes in NOD mice are linked to
differentiation and proliferation of hematopoietic stem cells
(HSCs) [21, 22]. Notably, bone marrow transplantation from
young BALB/c mice to NOD mice prevents and reverses
the development of autoimmune diabetes [21]. Langmuir et
al. [23] demonstrated that expression of the hematopoietic
differentiation antigen Ly6C, expressed on monocytes, neu-
trophils, and T cells [24, 25], is severely impaired in NOD
mice. An interruption in the flanking region of the Ly6C
gene upstream of the transcription initiation site is present
in the NODmice genome [26], which appears to hamper the
transcription. The Ly6C gene is not completely knocked out
in NOD mice, as some Ly6C expression is still detectable.
Stimulation by cytokines does not restore the expression of
the gene [26].
Knowledge regarding deviations in the development and
differentiation of HSCs and defects in myelopoiesis as well as
gut colonisation and gene expression heremight aid to under-
stand autoimmunity in NOD mice. We therefore compared
development and activation of the myeloid cell lineage and
GM composition in NOD and C57BL/6 mice focusing on the
very first days after birth and found significant differences
between the two strains, as regards both neonatal GM and
hematopoiesis.
We speculate that NODmice in the neonatal period have
an altered GM, which in turnmay influence the development
of the genetically deviating immune system.
2. Experimental Procedures
2.1. Animals and Tissue. NOD/BomTac and C57BL/6 mice
were purchased from Taconic (Hudson, NY, USA, and
Denmark, resp.) and housed in a barrier protected rodent
facility (Faculty of Health and Medical Science, University
of Copenhagen, Frederiksberg, Denmark) under standard
conditions in open cages without filter and with access to
water and food (Altromin 1324, Lage, Germany) ad libitum.
The two strains were mated separately and postnatal day 1
(PND 1) was defined as the day pups were born. 16–18 pubs
from each strain were euthanized at PND 1, 2, 4, 7, 21, 28, and
70 by decapitation (PND 1–7) and cervical dislocation (PND
21–70). 6–8 spleens from each strain were dissected, kept on
ice, and prepared for flow cytometry. 4–6 spleens, liver, and
intestine samples were transferred to RNAlater (Ambion) for
RNA and DNA extraction and further 2-3 spleens and livers
were collected for histopathology examinations.
The project was licensed by the National Committee
for Animal Experimentation under the Danish Ministry of
Food, Fisheries and Agriculture (http://www.indberetning
Table 1: Gene expression assays used for qPCR.
Gene Gene name Assay ID
Actb Actin, beta Mn00607939 s1
Elane Elastase, neutrophil expressed Mm01168928 g1
Arg1 Arginase Mm00475988 m1
Hp Haptoglobin Mn00516884 m1
Camp Cathelicidin antimicrobial peptide Mm00438285 m1
Reg3g Regenerating islet-derived 3 gamma Mm00441127 m1
Muc2 Mucin 2 Mm01276696 m1
.dyreforsoegstilsynet.dk/) operating according to the EU
directive 2010/63/EU (license number 2012-15-2934-00256-
C1).
2.2. Splenic Cell Suspensions. Preparation of single cell sus-
pensions was carried out by mechanical disruption of the
spleen. Splenocytes werewashed in ice cold sterile RPMI 1640
(Lonza), centrifuged for 10min (200 g, 4∘C). Erythrocytes
were lysed by resuspension in 4mL 0.2% sterile filtrated
saline for 30 sec., following addition of 4mL 1.6% saline. The
procedure was repeated until the pellet was visibly free of
erythrocytes. Cells were washed in RPMI, before viable cell
count.
2.3. Analysis of Cell Population. Splenic single cell suspen-
sions (1× 105–1× 106 cells/well) were incubated in the dark for
10minwith 3 𝜇g/mL anti-CD16/32 (BDBiosciences, Franklin
Lakes, NJ, USA). Subsequently the following antibodies were
added: anti-CD11b PE-cy7 clone M1/70, anti-Ly6C PE clone
AL-21, and Ly6G APC clone 1A8 (eBiosciences, San Diego,
CA, USA). Cells were analysed immediately on a FACScanto
flow cytometer (BD Biosciences). Data analysis and layouts
of FACS data were performed using Flowjo V 10.6 (Tree Star,
Ashland, OR, USA).
2.4. RNA Isolation, cDNA Synthesis, and Gene Expression
Analysis by qPCR. RNA extraction from samples stored in
RNAlater and subsequently cDNA synthesis were performed
as previously described [27].
Gene expression of Reg3g, Camp, Arg1, Elane, Hp, Muc2,
andActbwas analysed as previously described [27] in samples
from spleen, liver, and intestine using TaqMan Gene Expres-
sion Assays (Life Technology, Table 1). Fold changes in gene
expression were calculated as 2−ΔΔCt using the ΔΔCt method
[28]. Briefly the expression of each sample was normalized
to the expression of the reference (Actb) gene: (ΔCt =
Ct(target) − Ct(reference)), and the relative gene expres-
sion was calculated as (ΔΔCt = ΔCt(target) − ΔCt(control)),
where ΔCt(control) is the average ΔCt from NOD PND 1
samples.
2.5. MiSeq-Based 16S rRNA Gene Amplicon High Throughput
Sequencing. 31 mouse GM profiles were determined using
tag-encoded 16S rRNA gene amplicon MiSeq (Illumina)
based high throughput sequencing. DNA extraction and 16S
rRNA gene library preparation were performed as previously
described [29].
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The raw dataset was trimmed using the “trim sequences”
tool in CLC Genomic Workbench (CLC bio, Aarhus, Den-
mark). The fasta file format was made compatible with the
Quantitative Insight Into Microbial Ecology (QIIME) open
source software package (1.8.0) with an in-house Matlab
script. Purging the dataset from chimeric reads and OTU
clustering was conducted using UPARSE-. TU [30]. The
relative distribution of the genera registered was calculated
for unified and summarized in the genus level OTU tables.
Alpha and beta-diversity measures, including analysis of
group differences based on uniFrac distance metrics and
ANOSIM analysis, were determined and analysed as previ-
ously described [29].
2.6. Generation and Harvest of Murine Bone Marrow-Derived
Cells. Bonemarrow cells were obtained from femur and tibia
from adult NOD and C57BL/6 mice as previously described
[31]. Cell suspensions were diluted to a concentration of 3
× 105 cells/mL containing GM-CSF and incubated at 37∘ in
a 5% CO
2
-incubator (day 0). On day 3 the cultured cells
were stimulated with Escherichia coli Nissle 1917 (MOI 0.1),
Lactobacillus acidophilus NCFM (MOI 0.1), or a mix of both
(MOI 0.05 each). The cells were harvested at day 6, stained
and analysed by flow cytometry.
2.7. Hematoxylin and Eosin (HE) Staining and Gram Staining.
Spleens, liver, and intestine were formalin fixed and paraf-
fin embedded, cut into 4 𝜇m thin sections, and mounted
on superfrost plus slides and HE stained. The slides were
evaluated by blinded visual inspection including an expe-
rienced pathologist. The degree of granulocytic infiltration
was scored as 0 (no infiltration), 1 (mild focal infiltration),
2 (moderate focal infiltration), or 3 (severe infiltration). The
proportion of hematopoietic tissue was scored using similar
criteria.
Liver and spleen tissue were cut into 4 𝜇m thin sections
and Gram-stained as described by Bancroft et al. [32].
2.8. Tissue Preparation and Projection Tomography (OPT)
Scanning. To visualize the intestinal anatomy at PND 1 in
NOD and C57BL/6 mice (two mice from each strain) the
intestine was dissected and processed for optical projection
tomography (OPT) as earlier described [33]. Each sample was
scanned using the Biotonics 3001 OPT scanner (Bioptonics,
Edinburgh, UK) at 425 nm with a rotation degree of 45∘
yielding 800 images with a resolution of 1024 × 1024 pixels.
All samples were scanned at the same exposure time and
same zoom factor. Scanswere reconstructedwith theNRecon
V. 1.6.9.3 (Skyscan) software and digital sections illustrated
in gray-scale demonstrating autofluorescence anatomy data
were prepared with the Bioptonic Viewer Software V.2.0
(Bioptonics).
2.9. Statistical Analysis. For all statistical analysis, a two-
way ANOVA test with Bonferroni post test was performed
by Graph Pad Prism version 5.02 (Graphpad Software,
San Diego, CA). In gene expression experiments, statistical
analysis was performed on ΔCt values as these are assumed
normally distributed as opposed to the fold change values.
Statistical significance was accepted at ∗𝑝 < 0.05, ∗∗𝑝 < 0.01,
and ∗∗∗𝑝 < 0.001.
3. Results
3.1. Newborn NOD Mice Deviate in the Ly6G+/Ly6C+ Spleno-
cyte Population. To test our hypothesis that neonatal NOD
mice are altered in their development of the immune system,
we stained splenocytes from 1–7-day-old NOD and C57BL/6
mice with the CD11b, Ly6G, and Ly6C specific antibodies.
Splenocytes from the two strains had significantly different
proportions of CD11b+ cells at PND 1 (Figure 1(a)). Fur-
thermore, they exhibited highly distinct expression profiles
of the two myeloid lineage markers (Figures 1(b)–1(d)).
Splenocytes from NOD mice held a high and increasing
proportion of CD11b+Ly6G+Ly6C− cells from PND 1–7
(Figure 1(b)), a minor proportion of CD11b+Ly6G−Ly6C+
cells (Figure 1(c)), and very little CD11b+Ly6G+Ly6C+ cells
(Figure 1(d)). In contrast, splenocytes from C57BL/6 mice
displayed a high proportion of CD11b+Ly6G+Ly6C+ cells,
an increasing proportion of CD11b+Ly6G−Ly6C+ cells, and
almost no CD11b+Ly6G+ Ly6C− cells (Figures 1(b)–1(d)).
3.2. Livers of Newborn NOD Mice Are Rich in Cells with a
Granulocytic Phenotype. The vast difference in the myeloid
differentiation patterns in spleens from newborn NOD and
C57BL/6 mice prompted us to inspect the hematopoietic tis-
sue in the livers of the newbornmice as well as characterizing
the phenotype of the cells present. Sections of haematoxylin
and eosin (HE) stained livers were visually examined with
regard to the number, type, and localization of myeloid
derived differentiating cells (Figure 2(a)). No difference in the
amount of hematopoietic tissue was observed (Figure 2(b))
and no difference was observed in the rate of differentiation
(Figure 2(c)). Assessment of the number of differentiated
cells in the liver sections demonstrated that, compared to
C57BL/6 mice, NOD mice had a significant higher level of
cells with a polylobed or ringed nuclei at PND 1, 2, and 4 in the
liver (Figure 2(c)). These cells were present in the liver as far
as to PND 70 in NOD mice, though in much lower numbers
than seen in the newborn mice.
Interestingly, in NOD mice the granulocytic phenotype
of cells accumulated around the hepatic portal veins at PND
1 (Figure 3(a)), while in the C57BL/6 mice these cells were
fewer and scattered in the tissue of the liver, with a gradient
towards the blood vessels (Figure 3(b)).While the twomouse
strains had similar numbers of hematopoietic stem cells in the
livers at PND 1, they differed greatly in the number and in the
localization of the differentiating granulocytic cells.
3.3. More Immature Granulocytes in the Spleen of NOD Mice
Compared to C57BL/6 Mice. Visual examination of neonatal
liver and spleen revealed a large proportion of granulocytic
cells in different differentiation stages in NOD mice com-
pared to C57BL/6mice. To further assess their differentiation
we measured the expression of Elane (neutrophil elastase),
Arg1 (arginase 1), and Hp (haptoglobin), all genes expressed
in various differentiation steps in granulocytes [34–36].
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Figure 1: The proportion of CD11b+Gr-1+ splenocytes of newborn NOD mice is high compared to C57BL/6. Flow cytometric analysis
of freshly isolated splenocytes from newborn NOD and C57BL/6 mice for the expression of CD11b, Ly6C, and Ly6G. (a) Time course
development of the proportion of viable CD11b+ spleen cells in NOD and C57BL/6 mice at PND 1, 2, 4, and 7. Graphs (b), (c), and (d)
depict gated Ly6G-Ly6C+ (d), Ly6G+Ly6C− (c), and Ly6G+Ly6C+ (e) double positive cells. Backgating confirmed that all three populations
were CD11b+. (e) Time course of the absolute number of viable cells in spleens of NOD and C5BL/6 mice. Data presented as mean ± SEM
(𝑛 = 8–12 spleens). ∗∗𝑝 < 0.05. ∗∗∗𝑝 < 0.001.
Journal of Diabetes Research 5
C57BL/6 PND 1
10x
NOD PND 1
(a)
4
3
2
1
0
1 2 4 7 21 28 70
PND
H
E 
sc
or
e o
f h
em
at
op
oi
et
ic
 ti
ss
ue
NOD
C57BL/6
(b)
4
3
2
1
0
1 2 4 7 21 28 70
PND
H
E 
sc
or
e g
ra
nu
lo
cy
te
s
NOD
C57BL/6
∗∗∗
(c)
Figure 2:The presence of granulocytic myeloid derived cells is high in NODmice livers. (a) Hematoxylin and eosin (HE) staining of neonatal
PND 1 liver tissue sections from NOD and C57BL/6 mice. Arrows indicate hematopoietic tissue in the liver of newborn mice at PND 1. 10x
magnification. (b) HE scores of hematopoietic tissue at PND 1–70 in NOD and C57BL/6 mice. Two persons evaluated HE score in a blinded
fashion (𝑛 = 3). (c) HE score of granulocytes at PND 1–70. ∗∗∗𝑝 < 0.001.
In both liver and spleen,Elane expressionwas significantly
higher in NOD mice at PND 1-2 and PND 1–4, compared
to C57BL/6 mice (Figures 4(a) and 3(b)). Arg1 expression
was similar between the two strains at PND 1–4; however,
Arg1 was 200x higher expressed in liver compared to spleen.
In spleen at days 2 and 4, Hp expression was higher in
NODmice (Figure 4(f)). No difference was observed in liver
(Figure 4(e)), butHpwas expressed 50x higher in spleen than
in liver, indicating that the final maturation of granulocytes
takes place outside the liver.
Visual examination of spleen sections revealed that
splenocytes from NOD mice had a tendency to ring-shaped
rather than polylobed morphology, indicating presence of
granulopoietic stage 1 myeloblasts. C57BL/6 mice had a pop-
ulation of cells displaying themore polylobedmorphology, of
more mature neutrophils (Figure 5), indicating that relatively
more immature granulocytes are present in the spleen and
liver of NOD mice.
3.4. Bone Marrow-Derived HSCs from NOD Mice Stimulated
with Bacteria Are Able to Differentiate into Ly6C+ Cells.
A deficiency in the coding region of Ly6C has previously
been described in NOD mice [26], which may explain the
low Ly6C cell profile observed in the spleen of the NOD
mice. To test if bacterial stimulation of the HSCs initiates
the expression of more Ly6C+ cells, we stimulated bone
marrow cells from adult NOD and C57BL/6 mice with a
mixture of Gram-positive and Gram-negative bacteria and
measured the expression of Ly6G and Ly6C (Figure 6). In
nonstimulated cells, cells fromC57BL/6mice expressed 18.3%
CD11b+Ly6G+Ly6C+ cells and 31.3% CD11b+Ly6G−Ly6C+
cells and almost no CD11b+Ly6G+Ly6C− cells. In contrast
and very similar to our findings in spleen cells from new
born mice, bone marrow cells from NOD mice exhibited a
high proportion of Ly6G+ cells 34.0% and 8.3% Ly6C+.When
stimulated with bacteria, bone marrow cells from NODmice
developed a higher proportion of cells CD11b+Ly6G−Ly6C+
6 Journal of Diabetes Research
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Figure 3: In NOD mice the granulocytic phenotype of cells accumulated around the hepatic portal veins. Hematoxylin and eosin (HE)
staining of neonatal PND 1–7 liver tissue sections from NOD (a) and C57BL/6 mice (b).
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Figure 4: Relative gene expression of genes expressed in differentiation of myeloid cells in liver and spleen at PND 1, 2, and 4 of NOD and
C57BL/6 mice. Data were normalized to Actb and then to C57BL/6 PND 1, which were defined as value 1. All samples were quantified in
triplicate. All groups were included in a 2-way ANOVA. ∗∗∗𝑝 < 0.001, 𝑝 < 0.05. (a) Expression of Elane encoding elastase in liver. (b)
Expression of Elane encoding elastase in spleen. (c) Expression of Arg1 encoding arginase in liver. (d) Expression of Arg1 encoding arginase
in spleen. (e) Expression of Hp encoding haptoglobin in liver. (f) Expression of Hp encoding haptoglobin in spleen.
8 Journal of Diabetes Research
NOD PND 1
60x
C57BL/6 PND 1
Figure 5: Hematoxylin and eosin (HE) staining of neonatal spleen PND 1 from NOD mice and C57BL/6. Arrows depict granulocytes at
different stage of granulopoiesis. 60x magnification.
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Figure 7: Relative gene expression of Camp, analyzed in intestine
tissue from NOD and C57BL/6.
(17.8%) of which 36.2% were CD11b+Ly6G+Ly6C+. For com-
parison, cells from C57BL/6 mice changed from expressing
both CD11b+Ly6G+Ly6C+ and CD11b+Ly6G−Ly6C+ cells to
almost exclusively expressing CD11b+Ly6G−Ly6C+ cells.
These results indicate that bacterial stimulation may
overcome the genetic predisposition, affecting the expression
of Ly6C.
3.5. Higher Expression of Reg3g in the Intestine of Neona-
tal NOD Mice Is Associated with a Restriction of Surface
Attachment of Gram-Positive Bacteria and a Low Expression
of Muc2. The production of the antimicrobial cathelicidin-
related antimicrobial peptide (Camp) and Reg3g in the
neonatal intestine changes duringmaturation [37].Campwas
equally expressed by the two strains and only before wean-
ing (Figure 7). In contrast, Reg3g that normally is weakly
produced until weaning [38] had increased expression in
NOD mice at PND 2–7 compared to C57BL/6 (Figure 8(a)).
Upregulation of Reg3g has been associated with an aberrant
production of the secreted mucus protein Muc2 [39]. Hence,
we measured the expression of Muc2 in the neonatal period
and found that Muc2 was significantly lower from PND 2–
7 in intestine of NOD mice (Figure 8(b)). Reg3g is proposed
to primarily target Gram-positive bacteria [18] and next we
examined Gram-stained sections of the intestine at PND 1–7.
Presence of both Gram-positive and Gram-negative bacteria
was observed in the lumen of both NOD and C57BL/6 mice
(Figure 8(c)) However, a limited number of bacteria were
observed close to the mucosal surface of villi in the NOD
intestine and those present were mostly Gram-negative. In
comparison, the C57BL/6 intestine had both Gram-positive
and Gram-negative bacteria associated with the mucosal
surface (Figure 8(c)).
Finally, intestinal morphology between C57BL/6 and
NOD mice differed between the strains, as the intestinal
villi of C57BL/6 showed a more dense and thick structure
compared to NODmice (Figure 8(d)).
3.6. Higher Abundance of Staphylococcus in NOD Mice Com-
pared to C56BL/6 Mice. To assess the gut microbiota at PND
1–7 we analyzed samples of the entire intestine of C57BL/6
and NOD mice by tag-encoded 16S rRNA gene amplicon
high throughput sequencing (6,238,023 fully overlapping raw
reads, 5,575,454 after chimera purging). Four samples with
less than 50,000 reads were excluded from further analysis.
Remaining samples yielded on average 179,081 reads (STD
+/−).
The number of observed bacterial species did not differ
significantly between NOD and C57BL/6 mice (observed
species NOD = 27.41 ± 12.33, C57BL/6 = 34.67 ± 20.17,
𝑡 = −1.2, 𝑝 = 0.26). ANOSIM analysis of uniFrac-based
distance metrics revealed that the GM of the 2 mice strains
did not differ significantly (unweighted 𝑅 = 0.053, 𝑝 = 0.163,
weighted 𝑅 = 0.077, 𝑝 = 0.094). Figure 9 shows the relative
distribution of bacterial genera on PND 1, 2, 4, and 7 of NOD
and C57BL/6 mice. The relative abundance of Staphylococcus
was found to be significantly higher in NOD mice compared
to C57BL/6 (𝑝(Bonferroni-corrected) = 0.030) (Figure 10).
4. Discussion
Despite increased knowledge on the pathogenesis of type
1 diabetes and the role of the immune response in the
development of type 1 diabetes in NODmice, the early stages
of the disease pathology remain poorly understood. Far the
most studies are done in mice three weeks of age or older,
in which the focus often is on the role of T cells infiltrating
the pancreas and connecting lymph nodes [40, 41]. The
events taking place prior to and causing this infiltration
are largely unknown. Activation and action of some cells
of the myeloid lineage are expected to be involved in the
activation and polarization of T cells and also in recruitment
of the T cells to the pancreas. Consequently, it is likely
that hematopoietic events involving myeloid cells and taking
place in the very early postnatal period are essential for the
development. The key role of the GM in the development of
type 1 diabetes in NODmice has been firmly established [42].
NOD mice housed under germ-free conditions develop type
1 diabetes while mice reared under conventional conditions
were demonstrated to be partly protected from the disease
[43, 44] and GMmanipulation through antibiotics or specific
diets have been found to lower the incidence of autoimmune
diabetes [6, 7]. The microbial influence on development and
maturation of neonate immunity is however still only sparsely
described but is likely to play a key role in the development
of type 1 diabetes. Others have provided evidence that
changes in the maternal microbiota during pregnancy and
delivery influence the development of the immune system in
NOD mice [40] and CS has been associated with increased
type 1 diabetes incidence in humans [13]. Furthermore, gut
bacteria were recently shown to be involved in regulation of
hematopoiesis [45].
We here show that the hematopoiesis and the GM and
the gut epithelium deviate in the NOD mice compared to
C57BL/6 mice in the very first postnatal period.The neonatal
expression of Reg3g andMuc2 in the gut is deviating in NOD
mice and this coincides with vast differences in the GM of
NOD and C57BL/6 mice and is perhaps most interesting, in
the number of bacteria associated with the mucosal surface.
In parallel with these findings, we show that the proportions
of Ly6C+ and Ly6G+ cells in the spleen of neonatal NOD
mice deviate vastly from that of C57BL/6 mice, as the Ly6G+
10 Journal of Diabetes Research
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Digital sections of the PND 1 intestine illustrated in gray-scale demonstrating autofluorescence anatomy data inNOD andC57BL/6. Intestinal
sections from C57BL/6 mice displayed more dens villi compared to NODmice.
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Figure 10: Microbiota composition of the intact intestine from
C57BL/6 and NOD mice at PND 1, 2, and 4 as determined by
16S rRNA gene amplicon high throughput sequencing. Presence of
Staphylococcus in the intestine of NOD and C57BL/6 mice. Data are
expressed as percentage of bacteria present in intestine. Data are
mean ± SEM (𝑛 = 4-5 intestines).
cells dominate and Ly6C+ cell number is very low in NOD
mice, but this can, at least in vitro, partly be circumvented by
bacterial stimulation.
At birth the spleen and the liver constitute major
hematopoietic tissues in mice and may represent important
sites for encounters between microorganisms and immune
system. Puga et al. found granulocytic infiltration of peri-
marginal-zones of the spleen after postnatal mucosal colo-
nization by microbes, showed the presence of bacterial 16s
ribosomal RNA in these areas in the spleen, and found
that the granulocytic phenotype was dependent on the
microbiota [46]. Hence, the presence of bacteria or microbial
components in the spleen (and liver) may influence the
hematopoiesis here.
In the present study we demonstrate that spleen cells
at PND 1–7 in NOD mice comprise a large population of
immature granulocytic cells expressing CD11b+Ly6G+Ly6C−,
while in C57BL/6 the far largest proportion of CD11b+ cells
were Ly6C+Ly6G+ cells.
The lack of Ly6C expression in the bone marrow cells of
NOD mice is long known [23, 26] and has been suggested to
influence the propensity to development of type 1 diabetes,
but the mechanism behind how these deviating myeloid cells
influence disease development is largely unknown. In vitro
we showed that bone marrow cells from NODmice exhibit a
similar Ly6C− cell profile as the spleen cells of newbornmice,
but these could be prompted to change to Ly6C expressing
cells by the addition of bacteria.Thus, the presence of bacteria
or microbial epitopes may have larger influence on a proper
immune development in NOD mice compared to other,
nondiabetic mouse strains.
Our microscopy data from NOD mice liver showed
a larger number of granulocytic cells than in livers of
C57BL/6 mice and abundant granulocyte like cells accumu-
lated around the hepatic veins although the same amount
of hematopoietic tissue present in NOD and C57BL/6 mice
from PND 1. This might indicate either an earlier efflux of
granulocytes from livers of C57BL/6 or a larger number of
granulocytes are formed in the NODmice. A postnatal efflux
of hematopoietic cells from liver to spleen has previously been
demonstrated inmice [47] and we showed here that in spleen
granulocytic cells in early (Elane expressing) as well as late
(Hp expressing) differential state are present while, in liver,
primarily early differential state granulocytes are present,
supporting the possibility that many immature granulocytes
migrate from liver to spleen. Also, in spleen both Elane and
Hpwere more highly expressed in NODmice and in the liver
only Elane was higher expressed furthermore indicative of
more granulocytic cells in these organs in NODmice.
It is well established that, during the first postnatal weeks,
Paneth cells are absent in the crypts of the mouse intestine
and in this period the intestinal epithelium expresses Camp
[37]. As expected, the expression of Camp decreased around
the time of weaning and, at this time (PND 28), mature
Paneth cells producing Reg3g are present. However, other
cells such as goblet cells and enterocytes have also been
demonstrated to express Reg3g [48] and are likely producers
of this defensin at this early stage. In contrast, the expression
of Muc2 was significantly lower in NOD mice compared to
C57BL/6 mice. We have earlier shown that the presence of
a full GM in the postnatal period leads to upregulation in
the gene transcription of Muc2 [49]. In the present study
we found that a larger number of bacteria were associated
with the mucosa of C57BL/6 mice compared to NOD mice,
which could be speculated to be the cause of the increased
Muc2 expression. A lower production of Muc2 would likely
influence the composition of the microbiota, as glycans of
mucin functions as source of nutrients for many bacteria
[50]. Paassen et al. [48] have recently demonstrated that
absence of Muc2 was followed by upregulation of Reg3g
in the intestine of muc2−/− mice. Thus, the low expression
of Muc2 could explain the upregulated level of Reg3g in
the NOD mice. When inspecting the morphology of the
intestine of the newbornmice byOPT scanning, we observed
considerablemorphological differences between PND 1NOD
and C57BL/6 mice, as NOD mice intestine showed a thinner
and less dense structure. Hence, physiological differences
as well as differences in gene expression which may affect
translocation of bacteria or microbial components from the
gut were seen.
Reg3g binds peptidoglycan [18], expressed on the sur-
face of Gram-positive bacteria. Our Gram-staining analysis
revealed both Gram-negative and Gram-positive bacteria in
the lumen of bothmice strains.While both classes of bacteria
were attached to the surface of the villi in the C57BL/6
mice, few Gram-negative bacteria were attached in NOD
mice intestine. Interestingly, a bacteria profile enriched in
Staphylococcuswas prevailing in the intestine of NODmice at
PND 1–4.This genus ofGram-positive bacteria has previously
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been associated with children delivered by caesarean section
and with an increased risk of developing type 1 diabetes
[51].The very different and less diverse bacterial composition
found in newborn NOD mice is likely to influence gene
expression in the gut and thus factors such as the mucus
thickness. Hildebrand et al. reported that genetics directs
20% of the GM composition [52] and genetics in the gut
epithelium may also be involved in our study, as the animals
were reared in the same animal facility and handled by
the same persons, giving different basis for colonisation of
bacteria. Interestingly, the high level of Staphylococci found
at PND 1–4 in NOD mice decreased dramatically at PND 7,
which is in correspondencewith the expression level ofReg3g.
Whether Staphylococci are directly involved in the expression
of Reg3g is however purely speculative.
In summary, we here demonstrate huge differences in the
hematopoiesis, in GM, and in gut epithelium between NOD
and C57BL/6 mice during the very first postnatal period.
We propose that these differences might be involved in the
predisposition for developing type 1 diabetes in the NOD
mice.
Highlights
(i) Hematopoiesis deviates in the NOD mice compared
to C57BL/6 mice in the postnatal period.
(ii) Neonatal expression of Reg3g and Muc2 in the gut is
deviating in NODmice.
(iii) Fewer bacteria attach to the intestinal surface in
neonatal NOD.
(iv) In vitro microbial stimulation of bone marrow cells
leads to changes in hematopoiesis.
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